Showing results (461-470 of 498) with videos related to
Sort By:
Pageof 50
The American Journal of Cardiology|October 1, 1986
Value of percutaneous transluminal coronary angioplasty after unsuccessful intravenous streptokinase therapy in acute myocardial infarctionA Y Fung, P Lai, E J Topol, et al.Journal of the American College of Cardiology|January 1, 1989
Thrombolysis and Angioplasty in Myocardial Infarction (TAMI-1) trial: influence of infarct location on arterial patency, left ventricular function and mortalityE R Bates, R M Califf, R S Stack, et al.The New England Journal of Medicine|April 28, 1988
A randomized controlled trial of hospital discharge three days after myocardial infarction in the era of reperfusionE J Topol, K Burek, W W O'Neill, et al.Circulation|May 1, 1994
Recombinant human superoxide dismutase (h-SOD) fails to improve recovery of ventricular function in patients undergoing coronary angioplasty for acute myocardial infarctionJ T Flaherty, B Pitt, J W Gruber, et al.The American Journal of Cardiology|May 12, 2001
The QUinapril Ischemic Event Trial (QUIET): evaluation of chronic ACE inhibitor therapy in patients with ischemic heart disease and preserved left ventricular functionB Pitt, B O'Neill, R Feldman, et al.American Heart Journal|October 1, 1991
Prospective, double-blind, placebo-controlled trial of low-dose amiodarone in patients with severe heart failure and asymptomatic frequent ventricular ectopyJ M Nicklas, W J McKenna, R A Stewart, et al.Lancet (London, England)|July 6, 1996
Effect of d-sotalol on mortality in patients with left ventricular dysfunction after recent and remote myocardial infarction. The SWORD Investigators. Survival With Oral d-SotalolA L Waldo, A J Camm, H deRuyter, et al.Circulation|February 1, 1987
A randomized, placebo-controlled trial of intravenous recombinant tissue-type plasminogen activator and emergency coronary angioplasty in patients with acute myocardial infarctionE J Topol, W W O'Neill, A B Langburd, et al.The New England Journal of Medicine|January 9, 1997
Medical care costs and quality of life after randomization to coronary angioplasty or coronary bypass surgery. Bypass Angioplasty Revascularization Investigation (BARI) InvestigatorsM A Hlatky, W J Rogers, I Johnstone, et al.The American Journal of Cardiology|April 29, 1998
Mortality in the Survival With ORal D-sotalol (SWORD) trial: why did patients die?C M Pratt, A J Camm, W Cooper, et al.Pageof 50